Related Experiment Video
Updated: Jun 25, 2026
16:18
Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
Published on: November 20, 2011
A pump-free microfluidic device for integrated multi-functional testing of tumor spheroids
Eliana Steinberg1, Gabriel D Azulay1, Alina Ruiz de Villa
1The Institute for Drug Research, The School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
APL Bioengineering
|June 24, 2026
Summary
A new pump-free platform enables long-term, physiologically relevant 3D cancer cell cultures and drug testing. This organ-on-a-chip technology simplifies complex experiments for cancer research and therapeutic development.
Area of Science:
- Biomedical Engineering
- Cancer Research
- Microfluidics
Background:
- Three-dimensional (3D) multicellular ex vivo cultures and organ-on-a-chip systems are vital for cancer research and drug testing.
- Current microfluidic platforms often require complex, costly pumping systems for continuous perfusion, limiting scalability and routine use.
Purpose of the Study:
- To develop a novel, pump-free vertical fluidic platform for spheroid formation, culture, and biological testing.
- To enable scalable, modular, and cost-effective 3D cell culture under continuous perfusion for cancer research.
Main Methods:
- A modular, 3D-printed culture chamber with integrated spheroid molds and syringe components was designed.
- A hydrogel-based flow resistor was employed to create passive pressure gradients for continuous perfusion.
- Three human ovarian cancer cell lines were cultured, and drug response to paclitaxel was evaluated.
Main Results:
- Uniform spheroids were formed and maintained viability and metabolic activity for up to one week.
- Measurable effects on spheroid growth and invasion were observed after paclitaxel treatment.
- Stable perfusion was maintained for approximately 3 days, with gradual decline until day 7.
Conclusions:
- The developed pump-free platform offers a scalable and modular solution for controlled 3D cell culture and multi-functional assays.
- This technology simplifies experimental setups by eliminating the need for external pumping systems.
- The platform facilitates physiologically relevant cancer research and drug testing applications.
